Gaudium IVF Makes Historic IPO Move in Fertility Sector

Gaudium IVF and Women Health Ltd has raised Rs 49.5 crore from anchor investors before its IPO, becoming the first fertility care company to enter public markets. The IPO aims to establish new IVF centers and pay off debts. The Indian IVF market is poised for significant growth.

On Thursday, Gaudium IVF and Women Health Ltd announced it has secured Rs 49.5 crore from anchor investors prior to its Initial Public Offering (IPO). The notable anchor investors include MERU Investment Fund PCC-CELL, Sanshi Fund I, and others, with shares allocated at Rs 79 each.

The company's Rs 165 crore IPO is set to open on February 20 and close on February 24. This strategic move marks Gaudium IVF as the first fertility care provider to explore public market avenues, with the share price band fixed at Rs 75-79, valuing the company at Rs 575 crore.

Founded by Manika Khanna, the company plans to use the IPO proceeds to expand its network by opening 19 new IVF centers across India. Gaudium's ambitious growth strategy aligns with the anticipated expansion of the Indian IVF market, projected to grow significantly by 2034.

(With inputs from agencies.)